It's easy for clinics to think of skincare retail as a nice add-on to revenue rather than a genuine part of patient outcomes. In reality, the right cosmeceutical recommendations directly affect how well and how long in-clinic treatments actually last, which makes retail conversations a clinical decision as much as a commercial one.
Chemical peels are often one of the first treatments a clinic offers, and one of the first categories that stops growing once a basic glycolic or lactic acid option is added to the menu. That's a missed opportunity. The peels category has expanded considerably, and a well-differentiated peel menu gives practitioners a genuinely useful entry point for patients who aren't ready for injectables but still want visible results.
PRP was one of the first regenerative treatments to reach mainstream aesthetic clinics, and for a while it fell slightly out of the spotlight as newer categories like polynucleotides and exosomes captured attention. That's shifting again, and it's worth practitioners understanding why PRP is back on more treatment menus, not as a replacement for newer regenerative options, but alongside them.
